Finally, in order to determine whether expression of the androgen-repressed NFκB target genes identified has prognostic potential in prostate cancer, we analyzed a publicly available patient data set with follow-up data from the cBio Cancer Genomics portal [41]. This evidence concerns the gene NFKB1 and prostate cancer.